Cox V, De Azevedo V, Stinson K, Wilkinson LS, Rangaka MX, et al.
2015-11-01 • International Journal of Tuberculosis and Lung Disease
2015-11-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND The World Health Organization recommends tuberculin skin tests (TSTs) where feasible to identify individuals most likely to benefit from isoniazid preventive therapy (IPT)...
Cassidy T, Cornell M, Runeyi P, Dutyulwa T, Kilani C, et al.
2022-01-25 • Journal of the International AIDS Society
2022-01-25 • Journal of the International AIDS Society
INTRODUCTION Youth living with HIV (YLWH) are less likely to initiate antiretroviral therapy (ART) and remain in care than older adults. It is important to identify effective strate...
Green A, De Azevedo V, Patten GE, Davies MA, Ibeto M, et al.
2014-06-02 • PLOS One
2014-06-02 • PLOS One
To combat the AIDS epidemic and increase HIV treatment access, the South African government implemented a nurse-based, doctor-supported model of care that decentralizes administration of...
2013-07-04 • Journal of the International AIDS Society
2013-07-04 • Journal of the International AIDS Society
Despite the rapid expansion of antiretroviral therapy (ART) programmes in developing countries, pre-treatment losses from care remain a challenge to improving access to treatment. Youth ...
Mohr E, Snyman L, Mbakaz Z, Caldwell J, De Azevedo V, et al.
2018-09-14 • PLOS One
2018-09-14 • PLOS One
BACKGROUND Self-administered treatment (SAT), a differentiated model of care for rifampicin-resistant tuberculosis (RR-TB), might address adherence challenges faced by patients and h...
Mohr E, Daniels J, Beko B, Isaakidis P, Cox V, et al.
2017-05-18 • PLOS One
2017-05-18 • PLOS One
BACKGROUND Daily directly-observed therapy (DOT) is recommended for rifampicin-resistant tuberculosis (RR-TB) patients throughout treatment. We assessed the impact of self-administer...
Mohr E, Ferlazzo G, Hewison CCH, De Azevedo V, Isaakidis P
2019-05-01 • Lancet Infectious Diseases
2019-05-01 • Lancet Infectious Diseases
Here we report on the final outcomes for the cohort of 28 patients from Armenia, India, and South Africa who initiated regimens containing the combination of bedaquiline and delamanid fr...
Mohr-Holland E, Reuter A, Furin J, Garcia-Prats AJ, De Azevedo V, et al.
2020-03-01 • eClinicalMedicine
2020-03-01 • eClinicalMedicine
BACKGROUND Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19...
Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, et al.
2018-05-03 • European Respiratory Journal
2018-05-03 • European Respiratory Journal
Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa. This was ...
Duvivier H, Decroo T, Nelson AM, Cassidy T, Mbakaz Z, et al.
2020-07-08 • Reproductive Health
2020-07-08 • Reproductive Health
Background
The Post Natal Club (PNC) model assures comprehensive care, including HIV and Maternal and Child Health care, for postpartum women living with HIV and their infants durin...
A community based drug resistant tuberculosis (DR-TB) program has been incrementally implemented in Khayelitsha, a high HIV and TB burden community in South Africa. We investigated loss ...
Mohr-Holland E, Apolisi I, Reuter A, De Azevedo V, Hill JE, et al.
2019-12-21 • Public Health Action
2019-12-21 • Public Health Action
Little is known about the barriers to post-exposure management of rifampicin-resistant tuberculosis (RR-TB) in older children and adolescents. We report on implementation lessons from a ...
